Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease
Top Cited Papers
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 14 (2) , 437-454
- https://doi.org/10.1053/beha.2001.0142
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- Complement Factor H Gene Mutation Associated with Autosomal Recessive Atypical Hemolytic Uremic SyndromeAmerican Journal of Human Genetics, 1999
- Circulating inflammatory cytokine levels in hemolytic uremic syndromePediatric Nephrology, 1999
- Recovery by Splenectomy in Patients with Relapsed Thrombotic Thrombocytopenic Purpura and Treatment Failure to Plasma ExchangeSeminars in Thrombosis and Hemostasis, 1995
- Morphologic and ultrastructural evidence for interleukin‐6 induced platelet activationAmerican Journal of Hematology, 1995
- Evidence that activation of platelet calpain is induced as a consequence of binding of adhesive ligand to the integrin, glycoprotein IIb-IIIa.The Journal of cell biology, 1993
- Epidemiology of the Hemolytic Uremic SyndromeNew England Journal of Medicine, 1991
- Inducible secretion of large, biologically potent von Willebrand factor multimersCell, 1986
- Hemolytic Uremic Syndrome — Then and NowNew England Journal of Medicine, 1985
- Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1982